{"id":"saline-solution-nacl-0-9","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperchloremic acidosis (with large-volume infusion)"},{"rate":null,"effect":"Fluid overload / pulmonary edema (in susceptible patients)"},{"rate":null,"effect":"Hypernatremia (rare, with excessive administration)"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Normal saline is an isotonic crystalloid solution containing 0.9% sodium chloride (154 mEq/L each of Na+ and Cl−), which matches the osmolarity of blood plasma (~308 mOsm/L). It is used for fluid replacement and electrolyte supplementation without causing cellular water shifts. The solution distributes primarily to the extracellular compartment and is used for hydration, maintenance of electrolyte balance, and as a vehicle for intravenous medications.","oneSentence":"Saline solution (0.9% NaCl) restores fluid and electrolyte balance by providing isotonic sodium chloride that matches blood osmolarity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:36.665Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration"},{"name":"Maintenance of intravascular volume during surgery or critical illness"},{"name":"Vehicle for intravenous medication administration"},{"name":"Treatment of hyponatremia (in specific clinical contexts)"}]},"trialDetails":[{"nctId":"NCT07146776","phase":"NA","title":"Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts","status":"RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-07-12","conditions":"Periodontitis, Intrabony Periodontal Defect, Periodontal Diseases","enrollment":16},{"nctId":"NCT06799494","phase":"PHASE4","title":"HPV Vaccine Reduced Dose","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-08-06","conditions":"HPV","enrollment":100},{"nctId":"NCT04894435","phase":"PHASE2","title":"Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2021-05-20","conditions":"COVID-19","enrollment":669},{"nctId":"NCT05964985","phase":"NA","title":"Effect of Quadratus Lumborum Block With Compound Lidocaine and Esketamine on Pain After Colorectal Surgery","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2023-08-06","conditions":"Postoperative Pain","enrollment":160},{"nctId":"NCT05435755","phase":"EARLY_PHASE1","title":"Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2022-12-02","conditions":"Parkinson's Disease","enrollment":12},{"nctId":"NCT04667637","phase":"PHASE2","title":"Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol","status":"COMPLETED","sponsor":"Hui-Sheng Chen","startDate":"2021-02-23","conditions":"Stroke, Endovascular Thrombectomy","enrollment":200},{"nctId":"NCT05175781","phase":"NA","title":"Sedation for Non-invasive Ventilation in Blunt Chest Trauma","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2022-01-18","conditions":"Chest Trauma","enrollment":45},{"nctId":"NCT05132595","phase":"NA","title":"Esketamine vs. Ketorolac for Prevention of Postoperative Pain and Cognitive Dysfunction After Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2021-11-30","conditions":"Postoperative Pain, Postoperative Cognitive Dysfunction, Total Knee Arthroplasty","enrollment":160},{"nctId":"NCT01374516","phase":"PHASE3","title":"Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2011-06-08","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Dengue","enrollment":20869},{"nctId":"NCT05286008","phase":"NA","title":"Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2022-03-18","conditions":"Postoperative Nausea and Vomiting, Postoperative Pain","enrollment":90},{"nctId":"NCT04938882","phase":"NA","title":"Effect of Transversus Abdominis Plane Block With Compound Lidocaine on Pain After Gynecological Surgery","status":"COMPLETED","sponsor":"Tianjin Medical University General Hospital","startDate":"2021-08-15","conditions":"Postoperative Pain","enrollment":164},{"nctId":"NCT04465565","phase":"NA","title":"Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test","status":"WITHDRAWN","sponsor":"Rabin Medical Center","startDate":"2020-12","conditions":"Growth Hormone Deficiency","enrollment":""},{"nctId":"NCT05122338","phase":"NA","title":"Effect of Transversus Abdominis Plane Block With Compound Lidocaine and Esketamine on Pain After Surgery","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2021-12-01","conditions":"Postoperative Pain","enrollment":160},{"nctId":"NCT03450915","phase":"PHASE3","title":"A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine","status":"COMPLETED","sponsor":"BiondVax Pharmaceuticals ltd.","startDate":"2018-08-01","conditions":"Influenza","enrollment":12460},{"nctId":"NCT03527355","phase":"PHASE2","title":"Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine","status":"COMPLETED","sponsor":"International Vaccine Institute","startDate":"2018-04-18","conditions":"Typhoid","enrollment":285},{"nctId":"NCT04643132","phase":"NA","title":"S-ketamine Prevents Postoperative Pain and Cognitive Dysfunction After Tibial Fracture","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2020-12-15","conditions":"Postoperative Pain, Postoperative Cognitive Dysfunction","enrollment":120},{"nctId":"NCT03096730","phase":"NA","title":"Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia","status":"COMPLETED","sponsor":"Tianjin Medical University General Hospital","startDate":"2017-02-06","conditions":"Pain, Anesthesia","enrollment":150},{"nctId":"NCT04844996","phase":"EARLY_PHASE1","title":"Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis","status":"COMPLETED","sponsor":"Mersin University","startDate":"2019-09-01","conditions":"Endometriosis","enrollment":18},{"nctId":"NCT03500120","phase":"","title":"Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2017-09-01","conditions":"Primary Aldosteronism","enrollment":200},{"nctId":"NCT00986960","phase":"PHASE2","title":"Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)","status":"WITHDRAWN","sponsor":"University at Buffalo","startDate":"2009-12","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT00897676","phase":"PHASE1, PHASE2","title":"Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity","status":"COMPLETED","sponsor":"Diva De Leon","startDate":"2009-05","conditions":"Congenital Hyperinsulinism","enrollment":17},{"nctId":"NCT02687373","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2016-07-21","conditions":"Malaria","enrollment":337},{"nctId":"NCT03420053","phase":"PHASE1","title":"Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2018-02-07","conditions":"Malaria, Malaria,Falciparum","enrollment":21},{"nctId":"NCT00801931","phase":"PHASE1, PHASE2","title":"Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders","status":"TERMINATED","sponsor":"Columbia University","startDate":"2007-09-06","conditions":"Leukemia, Lymphoma, Neuroblastoma","enrollment":1},{"nctId":"NCT02333591","phase":"PHASE4","title":"Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults","status":"COMPLETED","sponsor":"Mette Zander","startDate":"2016-07","conditions":"Coronary Microvascular Dysfunction","enrollment":25},{"nctId":"NCT02679274","phase":"EARLY_PHASE1","title":"Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2016-02-16","conditions":"Aging","enrollment":3},{"nctId":"NCT01649921","phase":"PHASE3","title":"The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2012-11","conditions":"Sepsis, Septic Shock","enrollment":4},{"nctId":"NCT00912496","phase":"PHASE1","title":"Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-06","conditions":"Influenza","enrollment":637},{"nctId":"NCT01442519","phase":"PHASE3","title":"Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer","status":"COMPLETED","sponsor":"University of Rome Tor Vergata","startDate":"1994-01","conditions":"Bladder Cancer","enrollment":212}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Saline solution"],"phase":"marketed","status":"active","brandName":"Saline Solution (NaCl 0,9%)","genericName":"Saline Solution (NaCl 0,9%)","companyName":"Université du Québec à Trois-Rivières","companyId":"universit-du-qu-bec-trois-rivi-res","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline solution (0.9% NaCl) restores fluid and electrolyte balance by providing isotonic sodium chloride that matches blood osmolarity. Used for Fluid and electrolyte replacement in dehydration, Maintenance of intravascular volume during surgery or critical illness, Vehicle for intravenous medication administration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}